Impax Laboratories Inc. (IPXL) Tops Q2 EPS by 16c
Tweet
Share
E-mailGet Alerts IPXL Hot Sheet
Price: $18.30 --0%
Financial Fact:
Cost of revenues: 136.87M
Today's EPS Names:
ITG, MTEX, NSYS, More
Financial Fact:
Cost of revenues: 136.87M
Today's EPS Names:
ITG, MTEX, NSYS, More
Join SI Premium – FREE
Impax Laboratories Inc. (NASDAQ: IPXL) reported Q2 EPS of $0.60, $0.16 better than the analyst estimate of $0.44. Revenue for the quarter came in at $166.5 million versus the consensus estimate of $162.03 million.
For earnings history and earnings-related data on Impax Laboratories Inc. (IPXL) click here.
For earnings history and earnings-related data on Impax Laboratories Inc. (IPXL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
- UBS Downgrades FANUC Corp (6954:JP) (FANUY) to Neutral
- UBS Downgrades Borouge PLC (BOROUGE:UH) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
